Blagoje Murganic

7PUBLICATIONS
20CO-AUTHORS
NanomaterialsHaematological tumoursMolecular targetsBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 13, 2026
ERα-Independent Activity of Tamoxifen-Based Transition Metal Hybrids in Triple-Negative Breast Cancer Models In Vitro and In Vivo.

|Mar 28, 2026
Assessment of the Type and Degree of Genomic Instability in Gliomas.

Nejla Ademović, Marina Milić, Tijana Tomić

|Dec 30, 2025
The Impact of Decreased GSK3β and S6K1 Expression in TNBC Patients.

Tijana Tomić, Mirjana Prvanović, Jovan Jevtić

|Jun 24, 2024
Bipyraloxifene - a modified raloxifene vector against triple-negative breast cancer.

Aleksandr Kazimir, Tom Götze, Blagoje Murganić

|Apr 20, 2024
Exploring Raloxifene-Based Metallodrugs: A Versatile Vector Combined with Platinum(II), Palladium(II) and Nickel(II) Dichlorides and Carborates against Triple-Negative Breast Cancer.

Aleksandr Kazimir, Tom Götze, Peter Lönnecke

|Jul 27, 2022
Carborane-Based Analog of Rev-5901 Attenuates Growth of Colon Carcinoma In Vivo.

Svetlana Paskaš, Blagoje Murganić, Robert Kuhnert

Pageof 2

Frequent Collaborators

5 joint publications

Danijela Maksimović-Ivanić

5 joint publications

Evamarie Hey-Hawkins

4 joint publications

Sanja Mijatović

2 joint publications

Nasta Tanić